Linetsky David's Form 4 filing
Phreesia, Inc. (PHR) · filed May 9, 2025
- Accession no.
- 0001127602-25-013853
- Filed
- May 9, 2025
- Trade date
- Sep 15, 2022-Dec 18, 2023
- Filing delay
- 967 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $3.06K. It was filed 967 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Linetsky DavidCIK 0001776729 | Officer (SVP, Life Sciences) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Common Stock | AGrant or awardAcquired | +1,392 | $28.72 | +$39,978.24 | 9,792 | Indirect | |
| Dec 15, 2022 | Common Stock | SSaleDisposed | −22 | $34.01 | −$748.22 | 9,770 | Indirect | |
| Dec 18, 2023 | Common Stock | SSaleDisposed | −100 | $23.15F5 | −$2,315 | 9,904 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F5
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.96 to $23.33 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.